Allen Patricia L

CIK 00013485875 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001348587

Recent Transactions

50 trades

Award
Zenas BioPharma, Inc.$ZBIO
Stock Option (Right to Buy)
2025-06-10+18,500→ 18,500 total
Award
Zenas BioPharma, Inc.$ZBIO
Stock Option (Right to Buy)
2024-09-12+18,500→ 18,500 total
Disposition to Issuer
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2024-06-11−12,000→ 0 total
Disposition to Issuer
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2024-06-11−4,727→ 0 total
Disposition to Issuer
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2024-06-11−10,233→ 0 total
Disposition to Issuer
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2024-06-11−9,570→ 0 total
Disposition to Issuer
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2024-06-11−3,269→ 0 total
Disposition to Issuer
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2024-06-11−30,000→ 0 total
Disposition to Issuer
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2024-06-11−18,500→ 0 total
Disposition to Issuer
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2024-06-11−7,181→ 0 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2024-01-16$10.58/sh+4,727→ 4,727 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2023-06-21+30,000→ 30,000 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2023-01-17$15.30/sh+3,269→ 3,269 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2022-06-23+18,500→ 18,500 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2022-01-18$5.22/sh+9,570→ 9,570 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2021-06-23+12,000→ 12,000 total
Award
KINETA, INC./DE
Stock Option (Right to Buy)
2021-06-02+14,800→ 14,800 total
Award
KINETA, INC./DE
Stock Option (Right to Buy)
2020-12-22+5,271→ 5,271 total
Award
KINETA, INC./DE
Stock Option (Right to Buy)
2020-12-22+12,495→ 12,495 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-06-10+12,000→ 12,000 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-06-05−5,635→ 0 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Common Stock
2020-06-05$25.73/sh+5,635→ 5,635 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2020-06-05$55.90/sh−5,635→ 0 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-06-03−6,365→ 5,635 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2020-06-03$59.14/sh−6,365→ 0 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Common Stock
2020-06-03$25.73/sh+6,365→ 6,365 total
Conversion
Deciphera Pharmaceuticals, Inc.
Common Stock
2020-01-24$3.95/sh+25,000→ 25,000 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2020-01-24$67.36/sh−700→ 0 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2020-01-24$66.55/sh−6,496→ 700 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-01-24+25,000→ 10,233 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2020-01-24$65.93/sh−17,804→ 7,196 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2019-06-11+12,000→ 12,000 total
Award
Larimar Therapeutics, Inc.$LRMR
Stock Option (Right to Buy)
2019-01-22+125,000→ 125,000 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2018-05-17+12,000→ 12,000 total
Award
Larimar Therapeutics, Inc.$LRMR
Stock Option (Right to Buy)
2018-02-22+125,000→ 125,000 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2017-10-02−6,236→ 0 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2017-10-02+35,233→ 35,233 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2017-10-02+7,181→ 7,181 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2017-10-02−1,271→ 0 total
Award
Larimar Therapeutics, Inc.$LRMR
Stock Option (Right to Buy)
2017-01-27+88,000→ 88,000 total
Purchase
Larimar Therapeutics, Inc.$LRMR
Common Stock
2016-07-26$3.15/sh+8,200→ 19,793 total
Purchase
Larimar Therapeutics, Inc.$LRMR
Common Stock
2016-07-25$3.08/sh+7,800→ 11,593 total
Award
Larimar Therapeutics, Inc.$LRMR
Stock Option (Right to Buy)
2016-03-31+36,000→ 36,000 total
Award
Larimar Therapeutics, Inc.$LRMR
Stock Option (Right to Buy)
2016-03-31+72,000→ 72,000 total
Award
Larimar Therapeutics, Inc.$LRMR
Stock Option (Right to Buy)
2015-02-27+60,000→ 187,388 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2010-12-08+25,000→ 25,000 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2009-12-10+25,000→ 25,000 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2009-04-22$0.95/sh+25,000→ 25,000 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2009-04-22$17.63/sh−25,000→ 0 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Non-Qualified Stock Option
2009-04-22+25,000→ 33,947 total

Companies

Recent Filings

Address

300 THIRD STREET

CAMBRIDGE, MA, 02142

View on SEC.gov